Antoine Yver

Chairman

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

CNTA

Current role

Chairman

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2023	Centessa Pharmaceuticals plc (CNTA)	M.D., M.Sc. Chairman of Development	$538,200	$221,738	$297,220	$310,381	—	$13,200	$1,380,739
2022	Centessa Pharmaceuticals plc (CNTA)	M.D., M.Sc. Chairman of Development	$517,500	$196,650	$517,000	$1,273,882	—	$12,200	$2,517,232
2021	Centessa Pharmaceuticals plc (CNTA)	M.D., M.Sc. Executive Vice President andChairman of Development	$312,500	$125,479	$16,677,940	—	—	$11,600	$17,127,519
2020	Centessa Pharmaceuticals plc (CNTA)	M.D., M.Sc. Executive Vice President andChairman of Development	—	—	—	—	—	—	—

No earnings-call appearances or filed executive changes recorded yet.